{
    "2018-08-02": [
        [
            {
                "time": "2018-08-01",
                "original_text": "Drugmaker Lilly's Elanco animal health unit files for IPO",
                "features": {
                    "keywords": [
                        "Elanco",
                        "IPO",
                        "animal health"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "Diabetes Superpower Eli Lilly's Results",
                "features": {
                    "keywords": [
                        "Diabetes",
                        "Eli Lilly",
                        "Results"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-03",
                "original_text": "Eli Lilly's Animal-Health Business Files for Initial Public Offering",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Animal-Health",
                        "IPO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-04",
                "original_text": "Elanco Animal Health Files IPO Registration Statement",
                "features": {
                    "keywords": [
                        "Elanco",
                        "Animal Health",
                        "IPO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-05",
                "original_text": "Diabetes Superpower Eli Lilly's Results",
                "features": {
                    "keywords": [
                        "Diabetes",
                        "Eli Lilly",
                        "Results"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-06",
                "original_text": "United Therapeutics (UTHR) Q2 Earnings Flat Y/Y, Shares Dip",
                "features": {
                    "keywords": [
                        "United Therapeutics",
                        "Q2",
                        "Earnings",
                        "Shares Dip"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-07",
                "original_text": "Is a Beat in Store for Radius Health (RDUS) in Q2 Earnings?",
                "features": {
                    "keywords": [
                        "Radius Health",
                        "Q2",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-08",
                "original_text": "Eli Lilly’s Neuroscience Products Sales Dropped in Q2 2018",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Neuroscience",
                        "Sales Dropped",
                        "Q2 2018"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-09",
                "original_text": "What DexCom Just Said About Its Future",
                "features": {
                    "keywords": [
                        "DexCom",
                        "Future"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-10",
                "original_text": "Eli Lilly’s Q2 2018 Earnings: Oncology Products",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q2 2018",
                        "Earnings",
                        "Oncology Products"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-11",
                "original_text": "Pfizer’s Xeljanz Receives Marketing Authorization in EU",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Xeljanz",
                        "Marketing Authorization",
                        "EU"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-12",
                "original_text": "How Is Merck’s Diabetes and Women’s Health Business Positioned?",
                "features": {
                    "keywords": [
                        "Merck",
                        "Diabetes",
                        "Women’s Health",
                        "Business"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-13",
                "original_text": "LLY’s Cardiovascular Products: Cialis and Effient Q2 Sales Fall",
                "features": {
                    "keywords": [
                        "LLY",
                        "Cardiovascular",
                        "Cialis",
                        "Effient",
                        "Q2 Sales Fall"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}